Total Payments
$477,357
2024 Payments
$74,222
Companies
34
Transactions
1,186
Payment Breakdown by Category
Other$254,269 (53.3%)
Consulting$157,504 (33.0%)
Travel$36,812 (7.7%)
Food & Beverage$28,250 (5.9%)
Research$420.00 (0.1%)
Education$100.75 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $235,369 | 159 | 49.3% |
| Consulting Fee | $157,504 | 61 | 33.0% |
| Travel and Lodging | $36,812 | 128 | 7.7% |
| Food and Beverage | $28,250 | 804 | 5.9% |
| Honoraria | $18,900 | 19 | 4.0% |
| Unspecified | $420.00 | 1 | 0.1% |
| Education | $100.75 | 14 | 0.0% |
Payments by Type
General
$476,937
1,185 transactions
Research
$420.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EISAI INC. | $146,924 | 207 | $0 (2022) |
| UCB, Inc. | $119,216 | 405 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $41,805 | 135 | $0 (2022) |
| Neurelis, Inc. | $35,990 | 44 | $0 (2024) |
| Greenwich Biosciences, Inc. | $22,795 | 66 | $0 (2021) |
| AQUESTIVE THERAPEUTICS, INC. | $17,279 | 49 | $0 (2022) |
| CATALYST PHARMACEUTICALS, INC. | $16,946 | 22 | $0 (2024) |
| Marinus Pharmaceuticals, Inc. | $16,868 | 39 | $0 (2024) |
| Zogenix Inc. | $12,692 | 18 | $0 (2021) |
| SK Life Science, Inc. | $8,294 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74,222 | 195 | UCB, Inc. ($43,569) |
| 2023 | $38,677 | 113 | UCB, Inc. ($14,879) |
| 2022 | $76,829 | 142 | UCB, Inc. ($27,817) |
| 2021 | $50,626 | 126 | Eisai Inc. ($15,899) |
| 2020 | $47,767 | 103 | Eisai Inc. ($20,514) |
| 2019 | $54,225 | 200 | EISAI INC. ($23,489) |
| 2018 | $69,943 | 190 | Sunovion Pharmaceuticals Inc. ($27,920) |
| 2017 | $65,066 | 117 | Eisai Inc. ($45,400) |
All Payment Transactions
1,186 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 12/30/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $103.31 | General |
| 12/30/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $59.12 | General |
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Neurology | ||||||
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Neurology | ||||||
| 12/13/2024 | UCB SA | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| Category: Neurology | ||||||
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $135.36 | General |
| Category: Neurology | ||||||
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $45.83 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $199.67 | General |
| 12/08/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $100.16 | General |
| 12/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2024 | BIOCODEX, INC. | DIACOMIT (Drug) | Food and Beverage | In-kind items and services | $70.16 | General |
| Category: Antiepileptic | ||||||
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.25 | General |
| 12/06/2024 | BIOCODEX, INC. | DIACOMIT (Drug) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: Antiepileptic | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $47.49 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $46.71 | General |
| Category: EPILEPSY | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $37.02 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $31.43 | General |
| 12/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $6.70 | General |
| 12/05/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $144.50 | General |
| 12/05/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $22.25 | General |
| 12/05/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $22.25 | General |
| 12/03/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $6.70 | General |
| 11/25/2024 | Marinus Pharmaceuticals, Inc. | ZTALMY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: SEIZURE DISORDERS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| The Seizure Termination Project: Expert Consensus Recommendations for the Rapid Termination of Seizure Emergencies.The Seizure Termination Project: Expert Consensus Recommendations for the Rapid Termination of Seizure Emergencies | UCB, Inc. | $420.00 | 1 |
About Dr. Michael Chez, MD
Dr. Michael Chez, MD is a Neurology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003998618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chez, MD has received a total of $477,357 in payments from pharmaceutical and medical device companies, with $74,222 received in 2024. These payments were reported across 1,186 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($235,369).
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology with Special Qualifications in Child Neurology
- Location Sacramento, CA
- Active Since 10/20/2006
- Last Updated 05/26/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003998618
Products in Payments
- Fycompa (Drug) $118,361
- Fintepla (Drug) $62,994
- APTIOM (Drug) $41,763
- VALTOCO (Drug) $35,990
- Epidiolex (Drug) $22,795
- Vimpat (Drug) $19,540
- Briviact (Drug) $19,374
- SYMPAZAN (Drug) $17,909
- Banzel (Drug) $17,276
- FYCOMPA (Drug) $16,946
- ZTALMY (Drug) $16,848
- XCOPRI (Drug) $7,988
- EPIDIOLEX (Drug) $7,505
- ACTHAR (Biological) $5,976
- Nayzilam (Drug) $5,411
- ONFI (Drug) $4,191
- Cosyntropin (Drug) $2,100
- DIACOMIT (Drug) $1,596
- OXTELLAR XR (Drug) $1,564
- RNS System (Device) $1,368
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sacramento
Lin Zhang
Neurology — Payments: $584,671
Neurology $584,671
Dr. Michael Rogawski, M.d, M.D
Neurology — Payments: $214,540
Neurology $214,540
Dr. Yelena Usmanova, Md, MD
Neurology — Payments: $130,744
Neurology $130,744
Charles Decarli, Md, MD
Neurology — Payments: $127,304
Neurology $127,304
Maria Noelle Florendo, Md, MD
Neurology — Payments: $40,000
Neurology $40,000
Jack Lin, Md, MD
Neurology — Payments: $39,047
Neurology $39,047